Delivery Order SPE2DR25D1047-SPE2DR26F23W2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $43,600.80 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems....
- The Defense Logistics Agency awarded a $35,801.16 delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of October 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,942.92 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, a medication used to treat multiple sclerosis. This firm fixed price delivery order, awarded on August 26, 2025, represents a non-competitive, non-set-aside procurement with a completion date of August 27, 2025. The product will be performed and sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $31,415.33 delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with a completion date of October 30, 2025. This firm fixed price contract, awarded on October 29, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, will supply this interferon beta-1b...
- The Defense Logistics Agency awarded a $13,357.56 delivery order to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, serving the federal government's medical...
- The Defense Logistics Agency awarded a delivery order valued at $45,542.34 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $22,385.72 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits under a firm fixed price contract. This competitively awarded, non-set-aside delivery order was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,309.16 by the Defense Logistics Agency on November 25, 2025, for the supply of Betaseron 0.3 mg kits. The contract utilizes firm fixed pricing and carries an ultimate completion date of November 26, 2025. This award is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $28,856.00 to AmerisourceBergen Drug Corp for the supply of Betaseron 0.3 mg kits. The contract is firm fixed price with no set-aside designation and was competitively awarded. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The work will be performed in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $63,005.93 by the Defense Logistics Agency (DLA) on December 1, 2025, for the supply of Betaseron 0.3 mg kits. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 2, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- SPE2DR25D1047Indefinite Delivery Contract
- SPE2DR25D1047-SPE2DR26F23W2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,035.50 to AmerisourceBergen Drug Corp for Betaseron 0.3 mg kits, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 prime IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and functions as a global pharmaceutical support vehicle. The contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. Betaseron, an interferon beta-1b medication used to treat multiple sclerosis, represents a specialized pharmaceutical product within the company's extensive portfolio of brand-name and generic medications delivered through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.0k | 12/8/25 |